Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.65 |
| ▸ | MAPT | P10636 | 1/20 | 0.65 |
| ▸ | CES2 | O00748 | 4/20 | 0.62 |
| ▸ | CES1 | P23141 | 4/20 | 0.62 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.59 |
| ▸ | PPARG | P37231 | 7/20 | 0.59 |
| ▸ | PPARD | Q03181 | 7/20 | 0.59 |
| ▸ | PPARA | Q07869 | 7/20 | 0.59 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.59 |
| ▸ | TSHR | P16473 | 4/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | TLR2 | O60603 | 2/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | FABP4 | P15090 | 2/20 | 0.59 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.59 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | ESR1 | P03372 | 1/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2782616 | 1.00 | KMT2A (0.65) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL6840834 | 1.00 | KMT2A (0.65) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL888107 | 1.00 | KMT2A (0.65) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL105548 | 1.00 | KMT2A (0.65) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL19629035 | 1.00 | KMT2A (0.65) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL632531 | 1.00 | KMT2A (0.65) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL1153187 | 1.00 | KMT2A (0.65) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL21044695 | 1.00 | KMT2A (0.65) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL21044630 | 1.00 | KMT2A (0.65) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL966153 | 1.00 | KMT2A (0.65) | KMT2AMAPTCES2CES1GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 348 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114831299-A | Butter essence and production process thereof | 浙江澳杰生物技术有限公司 | 2022-08-02 | — | — | CN | claimed |
| CN-110172058-B | 7-azaspiro [5.6] dodecane-10-one compound and preparation method and application thereof | 中国医科大学 | 2021-06-04 | — | — | CN | claimed |
| EP-3649183-A1 | SILICONE COMPOUNDS | The Procter and Gamble Company (US) | 2020-05-13 | — | — | EP | claimed |
| EP-3649184-A1 | SILICONE COMPOUNDS | The Procter and Gamble Company (US) | 2020-05-13 | — | — | EP | claimed |
| US-20190010427-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2019-01-10 | — | — | US | claimed |
| US-20190010293-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2019-01-10 | — | — | US | claimed |
| WO-2019010265-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 2019-01-10 | — | — | WO | claimed |
| WO-2019010263-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 2019-01-10 | — | — | WO | claimed |
| CN-103709188-B | A kind of hydrosilation method prepares end-sealed type silane coupler containing sulfur technique | 江西晨光新材料有限公司 | 2017-03-15 | — | — | CN | claimed |
| CN-101357137-B | Use of a vitreoscilla filiformis lipopolysaccharide fraction as an agent for stimulating the synthesis of anti-microbial skin peptides | OREAL | 2015-06-17 | — | — | CN | claimed |
| US-20130190535-A1 | Method for Synthesis of Ketones from Plant Oils | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE | 2013-07-25 | — | — | US | claimed |
| EP-2272491-A1 | New deodorising compositions and deodorant products containing them | Robertet S.A. (FR) | 2011-01-12 | — | — | EP | claimed |
| EP-1132383-B1 | NOVEL AGAROFUAN DERIVATIVES, THEIR PREPARATION, PHARMACEUTICAL COMPOSITION CONTAINING THEM AND THEIR USE AS MEDICINE | INST OF MATERIA MEDICA OF CHIN (CN) | 2010-05-26 | — | — | EP | claimed |
| US-20090130051-A1 | Flavonoid Compounds and Uses Thereof | HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) | 2009-05-21 | — | — | US | claimed |
| CN-101357137-A | Use of a vitreoscilla filiformis lipopolysaccharide fraction as an agent for stimulating the synthesis of anti-microbial skin peptides | OREAL (FR) | 2009-02-04 | — | — | CN | claimed |
| US-6433152-B1 | BIOSURFACTANTS DERIVED FROM FERMENTATION OF YEASTS | AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO KG (DE) | 2002-08-13 | — | — | US | claimed |
| EP-1132383-A1 | NOVEL AGAROFUAN DERIVATIVES, THEIR PREPARATION, PHARMACEUTICAL COMPOSITION CONTAINING THEM AND THEIR USE AS MEDICINE | THE INSTITUTE OF MATERIA MEDICA OF CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2001-09-12 | — | — | EP | claimed |
| CN-1154979-A | Mold material made with additives | JOHNSON & JOHNSON VISION PROD (US) | 1997-07-23 | — | — | CN | claimed |
| US-5393760-A | Cardiovascular disorders, antitumor agents | HOFFMANN-LA ROCHE INC. (US) | 1995-02-28 | — | — | US | claimed |
| EP-0468231-B1 | Guanidins | HOFFMANN LA ROCHE (CH) | 1994-09-21 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090130051-A1 | Flavonoid Compounds and Uses Thereof | CAT, NQO1, GPX4 | KMT2A 4797/4885MAPT 3887/4885CES2 4106/4885 |
| US-20130190535-A1 | Method for Synthesis of Ketones from Plant Oils | FASN, DECR2, DECR1 | KMT2A 2969/4885MAPT 3193/4885CES2 1054/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.